News + Filings Transactions Holdings
|
THOMAS MCNERNEY & PARTNERS LP
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 04/20/2022 | Clarus Therapeutics Holdings, Inc. | | Sale | Common Stock | 1.7M | $2.53 | $4.2M | See footnote | 04/20/2022 |
| 04/20/2022 | Clarus Therapeutics Holdings, Inc. | | Sale | Common Stock | 2.1M | $2.53 | $5.2M | See footnote | 04/20/2022 |
| 04/20/2022 | Clarus Therapeutics Holdings, Inc. | | Sale | Common Stock | 5.7k | $2.53 | $14.5k | See footnote | 04/20/2022 |
| 04/20/2022 | Clarus Therapeutics Holdings, Inc. | | Sale | Common Stock | 13.6k | $2.53 | $34.5k | See footnote | 04/20/2022 |
| 04/20/2022 | Clarus Therapeutics Holdings, Inc. | | Sale | Common Stock | 1.2k | $2.53 | $2.9k | See footnote | 04/20/2022 |
| 04/20/2022 | Clarus Therapeutics Holdings, Inc. | | Sale | Common Stock | 7.6k | $2.53 | $19.2k | See footnote | 04/20/2022 |
| 04/20/2022 | CLARUS THERAPEUTICS INC | CRXT | Sale | Common Stock | 1.7M | $2.53 | $4.2M | See footnote | 04/20/2022 |
| 04/20/2022 | CLARUS THERAPEUTICS INC | CRXT | Sale | Common Stock | 2.1M | $2.53 | $5.2M | See footnote | 04/20/2022 |
| 04/20/2022 | CLARUS THERAPEUTICS INC | CRXT | Sale | Common Stock | 5.7k | $2.53 | $14.5k | See footnote | 04/20/2022 |
| 04/20/2022 | CLARUS THERAPEUTICS INC | CRXT | Sale | Common Stock | 13.6k | $2.53 | $34.5k | See footnote | 04/20/2022 |
| 04/20/2022 | CLARUS THERAPEUTICS INC | CRXT | Sale | Common Stock | 1.2k | $2.53 | $2.9k | See footnote | 04/20/2022 |
| 04/20/2022 | CLARUS THERAPEUTICS INC | CRXT | Sale | Common Stock | 7.6k | $2.53 | $19.2k | See footnote | 04/20/2022 |
| 04/06/2011 | Ocera Therapeutics, Inc. | OCRX | Conversion | Series A Convertible Preferred Stock | 55.9k | $0.00 | $0 | By TMP Associates, L.P. | 04/06/2011 |
| 04/06/2011 | Ocera Therapeutics, Inc. | OCRX | Conversion | Series A Convertible Preferred Stock | 547.2k | $0.00 | $0 | By TMP Nominee, LLC | 04/06/2011 |
| 04/06/2011 | Ocera Therapeutics, Inc. | OCRX | Conversion | Series A Convertible Preferred Stock | 14.7M | $0.00 | $0 | | 04/06/2011 |
| 04/06/2011 | Ocera Therapeutics, Inc. | OCRX | Purchase | Common Stock | 3k | $4.00 | $11.9k | By TMP Associates, L.P. | 04/06/2011 |
| 04/06/2011 | Ocera Therapeutics, Inc. | OCRX | Purchase | Common Stock | 14.6k | $4.00 | $58.3k | By TMP Nominee, LLC | 04/06/2011 |
| 04/06/2011 | Ocera Therapeutics, Inc. | OCRX | Purchase | Common Stock | 795k | $4.00 | $3.2M | | 04/06/2011 |
| 04/06/2011 | Ocera Therapeutics, Inc. | OCRX | Conversion | Common Stock | 8k | $0.00 | $0 | By TMP Associates, L.P. | 04/06/2011 |
| 04/06/2011 | Ocera Therapeutics, Inc. | OCRX | Conversion | Common Stock | 78.2k | $0.00 | $0 | By TMP Nominee, LLC | 04/06/2011 |
| 04/06/2011 | Ocera Therapeutics, Inc. | OCRX | Conversion | Common Stock | 2.1M | $0.00 | $0 | | 04/06/2011 |
| 05/18/2006 | Coley Pharmaceutical Group, Inc. | COLY | Other (disposition) | Common Stock | 1000k | $0.00 | $0 | See footnote | 05/18/2006 |
| 05/18/2006 | Coley Pharmaceutical Group, Inc. | COLY | Other (disposition) | Common Stock | 3.7k | $0.00 | $0 | See footnote | 05/18/2006 |
| 08/15/2005 | Coley Pharmaceutical Group, Inc. | COLY | Conversion | Common Stock | 2.1M | $0.00 | $0 | See | 08/15/2005 |
| 08/15/2005 | Coley Pharmaceutical Group, Inc. | COLY | Conversion | Common Stock | 677.9k | $0.00 | $0 | See | 08/15/2005 |
| 08/15/2005 | Coley Pharmaceutical Group, Inc. | COLY | Conversion | Common Stock | 7k | $0.00 | $0 | See | 08/15/2005 |
| 08/15/2005 | Coley Pharmaceutical Group, Inc. | COLY | Conversion | Common Stock | 3.3k | $0.00 | $0 | See | 08/15/2005 |
| 08/15/2005 | Coley Pharmaceutical Group, Inc. | COLY | Conversion | Series F Preferred Stock | 2.1M | $0.00 | $0 | See | 08/15/2005 |
| 08/15/2005 | Coley Pharmaceutical Group, Inc. | COLY | Conversion | Series G Preferred Stock | 677.9k | $0.00 | $0 | See | 08/15/2005 |
| 08/15/2005 | Coley Pharmaceutical Group, Inc. | COLY | Conversion | Series F Preferred Stock | 7k | $0.00 | $0 | See | 08/15/2005 |
| 08/15/2005 | Coley Pharmaceutical Group, Inc. | COLY | Conversion | Series G Preferred Stock | 3.3k | $0.00 | $0 | See | 08/15/2005 |
|